Clinical Trial Update: ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating ClAraC or FLAMSA conditioning regimens followed by stem cell transplantation for high-risk acute myeloid leukemia or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• ClAraC (cladribine + cytarabine)
• FLAMSA regimen (fludarabine + cytarabine + amsacrine regimen)

Snippet

Sponsor: Hannover Medical School | Conditions: Acute Myeloid Leukemia, MDS | Phase 2 | Status: UNKNOWN